CARBOPLATIN DOSING FOR ADULT JAPANESE PATIENTS

por ANDO, YUICHI, SHIMOKATA, TOMOYA, YASUDA, YOSHINARI, HASEGAWA, YOSHINORI
Publicado 2014

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

por Furune, Satoshi, Kondo, Chiaki, Takano, Yuko, Shimokata, Tomoya, Sugishita, Mihoko, Mitsuma, Ayako, Maeda, Osamu, Ando, Yuichi
Publicado 2021

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

por Furune, Satoshi, Kondo, Chiaki, Takano, Yuko, Shimokata, Tomoya, Sugishita, Mihoko, Mitsuma, Ayako, Maeda, Osamu, Ando, Yuichi
Publicado 2021

Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction

por Shibata, Takashi, Ebata, Tomoki, Fujita, Ken‐ichi, Shimokata, Tomoya, Maeda, Osamu, Mitsuma, Ayako, Sasaki, Yasutsuna, Nagino, Masato, Ando, Yuichi
Publicado 2016

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

por Takano, Yuko, Furune, Satoshi, Miyai, Yuki, Morita, Sachi, Inoue, Megumi, Shimokata, Tomoya, Sugishita, Mihoko, Mitsuma, Ayako, Maeda, Osamu, Ando, Yuichi
Publicado 2021

A rapid and durable response to larotrectinib in a patient with NTRK fusion-positive secretory carcinoma originating from the external auditory canal

por Ando, Yuichi, Morita, Sachi, Shimokata, Tomoya, Tsuzuki, Toyonori, Inafuku, Shigeru, Iwami, Kenichiro, Brega, Nicoletta, Akagawa, Takashi, Tsujino, Toshiaki, Ogawa, Tetsuya
Publicado 2022

EXTRAVASATION OF PEGYLATED-LIPOSOMAL DOXORUBICIN: FAVORABLE OUTCOME AFTER IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF CORTICOSTEROIDS

por MITSUMA, AYAKO, SAWAKI, MASATAKA, SHIBATA, TAKASHI, MORITA, SACHI, INADA, MEGUMI, SHIMOKATA, TOMOYA, SUGISHITA, MIHOKO, KITAGAWA, KOICHI, SAWADA, MASAKI, NAWA, AKIHIRO, ANDO, YUICHI
Publicado 2012

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review

por Maeda, Osamu, Ohka, Fumiharu, Maesawa, Satoshi, Matsuoka, Ayumu, Shimokata, Tomoya, Mitsuma, Ayako, Urakawa, Hiroshi, Nakamura, Shota, Shimoyama, Yoshie, Nakaguro, Masato, Wakabayashi, Toshihiko, Ando, Yuichi
Publicado 2020

Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft‐tissue sarcoma

por Yonemori, Kan, Kodaira, Makoto, Satoh, Taroh, Kudo, Toshihiro, Takahashi, Shunji, Nakano, Kenji, Ando, Yuichi, Shimokata, Tomoya, Mori, Joji, Inoue, Koichi, Oakley, Gerard J., Sakaguchi, Sachi, Tamura, Kenji
Publicado 2018

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies

por Minami, Hironobu, Doi, Toshihiko, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Mitsuma, Ayako, Shimokata, Tomoya, Naito, Yoichi, Matsubara, Nobuaki, Tajima, Takeshi, Tokushige, Kota, Ishihara, Kae, Cameron, Scott, Ando, Yuichi
Publicado 2020

Chemotherapy for biliary tract cancer: real-world experience in a single institute

por Maeda, Osamu, Ebata, Tomoki, Shimokata, Tomoya, Matsuoka, Ayumu, Inada-Inoue, Megumi, Morita, Sachi, Takano, Yuko, Urakawa, Hiroshi, Miyai, Yuki, Sugishita, Mihoko, Mitsuma, Ayako, Ando, Masahiko, Mizuno, Takashi, Nagino, Masato, Ando, Yuichi
Publicado 2020

Guidelines for clinical evaluation of anti‐cancer drugs

por Minami, Hironobu, Kiyota, Naomi, Kimbara, Shiro, Ando, Yuichi, Shimokata, Tomoya, Ohtsu, Atsushi, Fuse, Nozomu, Kuboki, Yasutoshi, Shimizu, Toshio, Yamamoto, Noboru, Nishio, Kazuto, Kawakami, Yutaka, Nihira, Shin‐ichi, Sase, Kazuhiro, Nonaka, Takahiro, Takahashi, Hideaki, Komori, Yukiko, Kiyohara, Koshin
Publicado 2021

Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review

por Kazama, Shingo, Morimoto, Ryota, Kimura, Yuki, Shibata, Naoki, Ozaki, Reina, Araki, Takashi, Mizutani, Takashi, Oishi, Hideo, Arao, Yoshihito, Kuwayama, Tasuku, Hiraiwa, Hiroaki, Kondo, Toru, Furusawa, Kenji, Shimokata, Tomoya, Okumura, Takahiro, Bando, Yasuko K., Ando, Yuichi, Murohara, Toyoaki
Publicado 2021

Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer

por Hatta, Takahiro, Hase, Tetsunari, Hara, Toru, Kimura, Tomoki, Kojima, Eiji, Abe, Takashi, Horio, Yoshitsugu, Goto, Yasuhiro, Ozawa, Naoya, Yogo, Naoyuki, Shibata, Hirofumi, Shimokata, Tomoya, Oguri, Tetsuya, Yamamoto, Masashi, Yanagisawa, Kiyoshi, Ando, Masahiko, Ando, Yuichi, Kondo, Masashi, Ishii, Makoto, Hasegawa, Yoshinori
Publicado 2023